Skip to content
March 13, 2024

Equity.Guru

Investment information for the new generation

Search

Veritas Pharmaceuticals

Biotech research outfit Veritas Pharma (VRT.C), which has locked up a multitude of big academics as it seeks to lock down the best strains to deal with pain and…
When I was running the editorial show at Stockhouse, I had reason to look over a lot of messageboards for a wide variety of public companies. Almost without fail,…
Rolling around the junior markets this morning, there’s considerable activity among many ‘friends of Equity.guru’ such as Veritas. Veritas Pharmaceuticals (VRT.C) announced this past week it has placed its…
Last December, Canadian Liberal Party mover/shaker, founding partner in Canopy Growth Corporation (CGC.V) and private equity player Chuck Rifici bought Wikileafs, the best named dispensary price comparison app out…
Medicinal cannabis research startup Veritas Pharmaceuticals (VRT.C) had a good day Tuesday when they received approval from Health Canada to legally perform cannabis research. Whistler Medical Marijuana will be…
Politics is a harsh mistress, but it gets considerably harsher when the ruling party decides to let anarchy reign because it suits their plans for reelection. Such was the…
Cannabis research play Veritas Pharmaceuticals (VRT.C) announced news after yesterday’s close, as predicted here at Equity.Guru, and the news was most definitely good. If you’re in the cancer research…
Had a long and detailed discussion last night with the very busy CEO of Veritas Pharma (VRT.C)*, Dr. Lui Franciosi, and came away pretty impressed with the man and his…